Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor class drugs

1 result
Asegua Therapeutics LLC
Usage: Sofosbuvir and velpatasvir is indicated for treating chronic hepatitis C virus (HCV) genotype 1-6 infection in adults and pediatric patients aged 3 years and older, including those without cirrhosis, with compensated cirrhosis, or with decompensated cirrhosis in combination with ribavirin.